{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Suffern",
      "state": "NY",
      "country": "United States",
      "classification": "Class III",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "68282",
      "recalling_firm": "Novartis Pharmaceuticals Corp.",
      "address_1": "25 Old Mill Rd",
      "address_2": "N/A",
      "postal_code": "10901-4106",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Nationwide",
      "recall_number": "D-1387-2014",
      "product_description": "Foradil Aerolizer (formoterol fumarate inhalation powder), 12 mcg per capsule, 60 Capsules, Rx only, Manufactured for: Merck, Sharpe & Dohne Corp., a subsidiary of Merck & Co., Inc. Whitehouse Station, NJ 08889,  Manufactured by: Novartis Pharma AG Basle, Switzerland NDC 0085-1401-01",
      "product_quantity": "Lot F0067: 45,834 units; Lot F0079: 63,321 units",
      "reason_for_recall": "Failed Stability Specification; out of specification result for particle size distribution during stability testing",
      "recall_initiation_date": "20140528",
      "center_classification_date": "20140617",
      "termination_date": "20150212",
      "report_date": "20140625",
      "code_info": "Lot F0067 exp. 06/14,  F0079 exp. 04/15",
      "more_code_info": ""
    }
  ]
}